Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Actinic Keratosis Treatment Market Growth & Trends
The global actinic keratosis treatment market size is anticipated to reach USD 8.93 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.1% from 2022 to 2030. The market is expected to witness growth opportunities owing to factors such as the wide availability of actinic keratosis therapeutics, rising awareness about the disease, and the rise in AK treatment. Moreover, the increasing prevalence of actinic keratosis and the rising geriatric population across the globe are expected to fuel the market growth during the forecast period.
Invasive squamous cell carcinoma may develop from AK when it becomes malignant (iSCC). Despite the fact that there are a number of potential causes for iSCC, AK is one of the most frequent ones. Additionally, basal cell carcinoma and non-melanoma skin cancer could result from AK. As a result, the demand for AK products across sales channels is being driven by the early diagnosis and treatment of actinic keratosis as a preventive strategy for comorbidities.
In addition, future pipeline medications and the increased use of combination therapy are key market drivers. For instance, Almirall, S.A. has Klisyri (extended label) in phase III of R&D. Furthermore, a rise in the acceptance and commercialization of innovative drugs is another factor that is predicted to fuel market growth. Moreover, increased R&D activities are expected to accelerate the approval of novel drugs used in the treatment of actinic keratosis, hence, propelling the growth over the forecast period.
Key players are adopting strategic initiatives such as product launches, partnerships, and expansion strategies to increase their market share across the globe. For instance, in June 2022, BIOFRONTERA AG announced that its license and marketing authorization holder Louis Widmer SA based in Switzerland has received an extension of its marketing authorization for the management of actinic keratosis in the trunk, extremities, and neck with Ameluz. Moreover, in July 2020, BIOFRONTERA AG announced that it has signed an agreement with Galenica AB for the marketing of BF-RhodoLED and Ameluz in Norway, Finland, Norway, and Iceland.
Actinic Keratosis Treatment Market Report Highlights
Actinic Keratosis Treatment Market Growth & Trends
The global actinic keratosis treatment market size is anticipated to reach USD 8.93 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.1% from 2022 to 2030. The market is expected to witness growth opportunities owing to factors such as the wide availability of actinic keratosis therapeutics, rising awareness about the disease, and the rise in AK treatment. Moreover, the increasing prevalence of actinic keratosis and the rising geriatric population across the globe are expected to fuel the market growth during the forecast period.
Invasive squamous cell carcinoma may develop from AK when it becomes malignant (iSCC). Despite the fact that there are a number of potential causes for iSCC, AK is one of the most frequent ones. Additionally, basal cell carcinoma and non-melanoma skin cancer could result from AK. As a result, the demand for AK products across sales channels is being driven by the early diagnosis and treatment of actinic keratosis as a preventive strategy for comorbidities.
In addition, future pipeline medications and the increased use of combination therapy are key market drivers. For instance, Almirall, S.A. has Klisyri (extended label) in phase III of R&D. Furthermore, a rise in the acceptance and commercialization of innovative drugs is another factor that is predicted to fuel market growth. Moreover, increased R&D activities are expected to accelerate the approval of novel drugs used in the treatment of actinic keratosis, hence, propelling the growth over the forecast period.
Key players are adopting strategic initiatives such as product launches, partnerships, and expansion strategies to increase their market share across the globe. For instance, in June 2022, BIOFRONTERA AG announced that its license and marketing authorization holder Louis Widmer SA based in Switzerland has received an extension of its marketing authorization for the management of actinic keratosis in the trunk, extremities, and neck with Ameluz. Moreover, in July 2020, BIOFRONTERA AG announced that it has signed an agreement with Galenica AB for the marketing of BF-RhodoLED and Ameluz in Norway, Finland, Norway, and Iceland.
Actinic Keratosis Treatment Market Report Highlights
- In 2021, the surgery segment dominated the market owing to the rising adoption of cryotherapy surgery in the management of actinic keratosis
- The nucleoside metabolic inhibitor segment held the largest share in 2021 and is expected to retain its dominance over the forecast period
- Asia Pacific is expected to register the highest CAGR over the forecast period due to factors such as the high prevalence of AK, rapidly evolving healthcare infrastructure, and rising healthcare expenditures by Asia Pacific countries
- North America dominated in 2021 due to the rising awareness among people about actinic keratosis, availability of robust treatment options, and improvements in healthcare infrastructure
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’S Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details OF Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country wise Market estimation using bottom up approach
1.6.1.3 Approach 3: Country wise Market estimation using top down approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 Key KoL Responses
1.10 Market Share Calculations
1.11 List of Secondary Sources
1.12 Objectives
1.12.1 Objective
1.12.2 Objective
1.13 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 ACTINIC KERATOSIS TREATMENT MARKET - INDUSTRY OUTLOOK
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Increasing prevalence of actinic keratosis coupled with rising geriatric population
3.3.1.2 Rising awareness among people and presence of robust treatment options
3.3.2 Market Restraints Analysis
3.3.2.1 Availability of generic preparations
3.3.2.2 Side effects associated with the drug treatment
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 NEW Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnership
3.7.5 Marketing & Promotions
3.7.5.1 Market entry strategies
3.7.9 Consumer Behavior Analysis
CHAPTER 4 ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS: THERAPY SCOPE, 2018 - 2030 (REVENUE, USD MILLION)
4.1 Actinic Keratosis Treatment Market: Therapy Movement Analysis
4.2 Surgery
4.2.1 Surgery Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Topical
4.3.1 Topical Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Photodynamic Therapy
4.4.1 Photodynamic Therapy Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 5 ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS: DRUG CLASS SCOPE, 2018 - 2030 (REVENUE, USD MILLION)
5.1 Actinic Keratosis Treatment Market: Drug Class Movement Analysis
5.2 Nucleoside Metabolic Inhibitor
5.2.1 Nucleoside Metabolic Inhibitor Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 NSAIDs
5.3.1 NSAIDS Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Immune Response Modifiers
5.4.1 Immune Response Modifiers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Photoenhancers
5.5.1 Photoenhancers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Photoenhancers
5.6.1 Photoenhancers Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS: END-USE SCOPE, 2018 - 2030 (REVENUE, USD MILLION)
6.1 Actinic Keratosis Treatment Market: End-use Movement Analysis
6.2 Hospitals
6.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Private Clinics
6.3.1 Private Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Homecare
6.4.1 Homecare Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS, REGIONAL SCOPE, 2018 - 2030, (REVENUE, USD MILLION)
7.1 Market Share Analysis by Region, 2021 & 2030
7.1.1 North America
7.1.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.1.3 Canada
7.1.1.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2 Europe
7.1.2.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.2 U.K.
7.1.2.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.3 Germany
7.1.2.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.4 France
7.1.2.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.5 Italy
7.1.2.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.6 Spain
7.1.2.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3 Asia-Pacific
7.1.3.1 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.3 China
7.1.3.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.4 India
7.1.3.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.5 South Korea
7.1.3.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.6 Australia
7.1.3.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.4 Latin America
7.1.4.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.4.3 Mexico
7.1.4.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.4.4 Argentina
7.1.4.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.5 Middle East And Africa
7.1.5.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.5.4 UAE
7.1.5.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 ACTINIC KERATOSIS TREATMENT MARKET: COMPETITIVE ANALYSIS
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Ansoff Matrix
8.2 Company Categorization
8.2.1 Innovators
8.2.1.1 Market Differentiators
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.3.3 Key Company Market Share Analysis, 2021
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.5 Private Companies
8.5.1 List Of Key Emerging Companies
8.6 Regional Network Map
8.7 Key Regional/Local Competitors for actinic keratosis treatment in Japan, Australia, Korea, India, Singapore, and Europe
8.8 Company Profiles
8.8.1 ALMIRALL S.A.
8.8.1.1 Company overview
8.8.1.2 Financial performance
8.8.1.3 Product benchmarking
8.8.1.4 Strategic initiatives
8.8.2 LEO PHARMA A/S
8.8.2.1 Company overview
8.8.2.2 Financial performance
8.8.2.3 Product benchmarking
8.8.2.4 Strategic initiatives
8.8.3 SUN PHARMACEUTICAL INDUSTRIES LTD.
8.8.3.1 Company overview
8.8.3.2 Financial performance
8.8.3.3 Product benchmarking
8.8.3.4 Strategic initiatives
8.8.4 NOVARTIS AG
8.8.4.1 Company overview
8.8.4.2 Financial performance
8.8.4.3 Product benchmarking
8.8.4.4 Strategic initiatives
8.8.5 GALDERMA
8.8.5.1 Company overview
8.8.5.2 Affymetrix
8.8.5.3 Company overview
8.8.5.4 Financial performance
8.8.5.5 Product benchmarking
8.8.5.6 Strategic initiatives
8.8.6 ORTHO DERMATOLOGICS (BAUSCH HEALTH COMPANIES INC.)
8.8.6.1 Company overview
8.8.6.2 Financial performance
8.8.6.3 Product benchmarking
8.8.6.4 Strategic initiatives
8.8.7 BIOFRONTERA AG
8.8.7.1 Company overview
8.8.7.2 Financial performance
8.8.7.3 Product benchmarking
8.8.7.4 Strategic initiatives
8.8.8 HILL PHARMACEUTICALS, INC.
8.8.8.1 Company overview
8.8.8.2 Financial performance
8.8.8.3 Product benchmarking
8.8.8.4 Strategic initiatives
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’S Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details OF Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country wise Market estimation using bottom up approach
1.6.1.3 Approach 3: Country wise Market estimation using top down approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 Key KoL Responses
1.10 Market Share Calculations
1.11 List of Secondary Sources
1.12 Objectives
1.12.1 Objective
1.12.2 Objective
1.13 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 ACTINIC KERATOSIS TREATMENT MARKET - INDUSTRY OUTLOOK
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Increasing prevalence of actinic keratosis coupled with rising geriatric population
3.3.1.2 Rising awareness among people and presence of robust treatment options
3.3.2 Market Restraints Analysis
3.3.2.1 Availability of generic preparations
3.3.2.2 Side effects associated with the drug treatment
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 NEW Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnership
3.7.5 Marketing & Promotions
3.7.5.1 Market entry strategies
3.7.9 Consumer Behavior Analysis
CHAPTER 4 ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS: THERAPY SCOPE, 2018 - 2030 (REVENUE, USD MILLION)
4.1 Actinic Keratosis Treatment Market: Therapy Movement Analysis
4.2 Surgery
4.2.1 Surgery Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Topical
4.3.1 Topical Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Photodynamic Therapy
4.4.1 Photodynamic Therapy Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 5 ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS: DRUG CLASS SCOPE, 2018 - 2030 (REVENUE, USD MILLION)
5.1 Actinic Keratosis Treatment Market: Drug Class Movement Analysis
5.2 Nucleoside Metabolic Inhibitor
5.2.1 Nucleoside Metabolic Inhibitor Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 NSAIDs
5.3.1 NSAIDS Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Immune Response Modifiers
5.4.1 Immune Response Modifiers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Photoenhancers
5.5.1 Photoenhancers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Photoenhancers
5.6.1 Photoenhancers Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS: END-USE SCOPE, 2018 - 2030 (REVENUE, USD MILLION)
6.1 Actinic Keratosis Treatment Market: End-use Movement Analysis
6.2 Hospitals
6.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Private Clinics
6.3.1 Private Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Homecare
6.4.1 Homecare Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS, REGIONAL SCOPE, 2018 - 2030, (REVENUE, USD MILLION)
7.1 Market Share Analysis by Region, 2021 & 2030
7.1.1 North America
7.1.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.1.3 Canada
7.1.1.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2 Europe
7.1.2.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.2 U.K.
7.1.2.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.3 Germany
7.1.2.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.4 France
7.1.2.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.5 Italy
7.1.2.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.2.6 Spain
7.1.2.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3 Asia-Pacific
7.1.3.1 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.3 China
7.1.3.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.4 India
7.1.3.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.5 South Korea
7.1.3.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.3.6 Australia
7.1.3.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.4 Latin America
7.1.4.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.4.3 Mexico
7.1.4.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.4.4 Argentina
7.1.4.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.5 Middle East And Africa
7.1.5.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.1.5.4 UAE
7.1.5.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 ACTINIC KERATOSIS TREATMENT MARKET: COMPETITIVE ANALYSIS
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Ansoff Matrix
8.2 Company Categorization
8.2.1 Innovators
8.2.1.1 Market Differentiators
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.3.3 Key Company Market Share Analysis, 2021
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.5 Private Companies
8.5.1 List Of Key Emerging Companies
8.6 Regional Network Map
8.7 Key Regional/Local Competitors for actinic keratosis treatment in Japan, Australia, Korea, India, Singapore, and Europe
8.8 Company Profiles
8.8.1 ALMIRALL S.A.
8.8.1.1 Company overview
8.8.1.2 Financial performance
8.8.1.3 Product benchmarking
8.8.1.4 Strategic initiatives
8.8.2 LEO PHARMA A/S
8.8.2.1 Company overview
8.8.2.2 Financial performance
8.8.2.3 Product benchmarking
8.8.2.4 Strategic initiatives
8.8.3 SUN PHARMACEUTICAL INDUSTRIES LTD.
8.8.3.1 Company overview
8.8.3.2 Financial performance
8.8.3.3 Product benchmarking
8.8.3.4 Strategic initiatives
8.8.4 NOVARTIS AG
8.8.4.1 Company overview
8.8.4.2 Financial performance
8.8.4.3 Product benchmarking
8.8.4.4 Strategic initiatives
8.8.5 GALDERMA
8.8.5.1 Company overview
8.8.5.2 Affymetrix
8.8.5.3 Company overview
8.8.5.4 Financial performance
8.8.5.5 Product benchmarking
8.8.5.6 Strategic initiatives
8.8.6 ORTHO DERMATOLOGICS (BAUSCH HEALTH COMPANIES INC.)
8.8.6.1 Company overview
8.8.6.2 Financial performance
8.8.6.3 Product benchmarking
8.8.6.4 Strategic initiatives
8.8.7 BIOFRONTERA AG
8.8.7.1 Company overview
8.8.7.2 Financial performance
8.8.7.3 Product benchmarking
8.8.7.4 Strategic initiatives
8.8.8 HILL PHARMACEUTICALS, INC.
8.8.8.1 Company overview
8.8.8.2 Financial performance
8.8.8.3 Product benchmarking
8.8.8.4 Strategic initiatives
LIST OF TABLES
1. List of Secondary Sources
2. List of Abbreviations
3. Actinic Keratosis Epidemiology
4. Product Pipeline
5. Regulatory Framework
6. Key Topical Products for Actinic Keratosis, 2021
7. Key Surgical Procedures for Actinic Keratosis, 2021
8. Key Photodynamic Therapeutics for Actinic Keratosis, 2021
9. Leading Market Players Anticipated to Witness Highest Growth
10. North America Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
11. North America Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
12. North America Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
13. U.S. Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
14. U.S. Actinic Keratosis Treatment Market, By Drug Class, 2022-2030 (USD Million)
15. U.S. Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
16. Canada Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
17. Canada Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
18. Canada Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
19. Europe Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
20. Europe Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
21. Europe Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
22. Germany Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
23. Germany. Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
24. Germany Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
25. U.K. Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
26. U.K. Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
27. U.K. Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
28. Italy Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
29. Italy Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
30. Italy Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
31. France Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
32. France Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
33. France Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
34. Spain Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
35. Spain Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
36. Spain Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
37. Asia Pacific Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
38. Asia Pacific Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
39. Asia Pacific Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
40. Japan Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
41. Japan. Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
42. Japan Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
43. China Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
44. China Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
45. China Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
46. India Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
47. India Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
48. India Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
49. South Korea Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
50. South Korea Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
51. South Korea Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
52. Australia Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
53. Australia Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
54. Australia Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
55. Latin America Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
56. Latin America Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
57. Latin America Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD million)
58. Brazil Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
59. Brazil Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
60. Brazil Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
61. Mexico Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
62. Mexico Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
63. Mexico Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
64. Argentina Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
65. Argentina Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
66. Argentina Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
67. MEA Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
68. MEA Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
69. MEA Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
70. South Africa Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
71. South Africa Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
72. South Africa Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
73. UAE Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
74. UAE Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
75. UAE Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
76. Saudi Arabia Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
77. Saudi Arabia Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
78. Saudi Arabia Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
1. List of Secondary Sources
2. List of Abbreviations
3. Actinic Keratosis Epidemiology
4. Product Pipeline
5. Regulatory Framework
6. Key Topical Products for Actinic Keratosis, 2021
7. Key Surgical Procedures for Actinic Keratosis, 2021
8. Key Photodynamic Therapeutics for Actinic Keratosis, 2021
9. Leading Market Players Anticipated to Witness Highest Growth
10. North America Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
11. North America Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
12. North America Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
13. U.S. Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
14. U.S. Actinic Keratosis Treatment Market, By Drug Class, 2022-2030 (USD Million)
15. U.S. Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
16. Canada Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
17. Canada Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
18. Canada Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
19. Europe Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
20. Europe Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
21. Europe Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
22. Germany Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
23. Germany. Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
24. Germany Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
25. U.K. Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
26. U.K. Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
27. U.K. Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
28. Italy Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
29. Italy Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
30. Italy Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
31. France Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
32. France Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
33. France Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
34. Spain Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
35. Spain Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
36. Spain Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
37. Asia Pacific Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
38. Asia Pacific Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
39. Asia Pacific Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
40. Japan Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
41. Japan. Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
42. Japan Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
43. China Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
44. China Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
45. China Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
46. India Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
47. India Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
48. India Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
49. South Korea Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
50. South Korea Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
51. South Korea Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
52. Australia Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
53. Australia Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
54. Australia Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
55. Latin America Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
56. Latin America Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
57. Latin America Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD million)
58. Brazil Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
59. Brazil Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
60. Brazil Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
61. Mexico Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
62. Mexico Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
63. Mexico Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
64. Argentina Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
65. Argentina Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
66. Argentina Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
67. MEA Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
68. MEA Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
69. MEA Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
70. South Africa Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
71. South Africa Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
72. South Africa Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
73. UAE Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
74. UAE Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
75. UAE Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
76. Saudi Arabia Actinic Keratosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
77. Saudi Arabia Actinic Keratosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
78. Saudi Arabia Actinic Keratosis Treatment Market, By End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
1. Actinic keratosis treatment market segmentation
2. Market research process
3. Data triangulation techniques
4. Primary research pattern
5. Market research approaches
6. Value-chain-based sizing & forecasting
7. QFD modeling for market share assessment
8. Market formulation & validation
9. Actinic keratosis treatment market snapshot
10. Parent market outlook
11. Related/ancillary market outlook, revenue, 2021, USD Billion
12. Penetration and growth prospect mapping
13. Actinic keratosis treatment market driver impact
14. Actinic Keratosis Treatment market restraint impact
15. SWOT analysis, by factor (Political & legal, economic, and technological)
16. Industry Analysis - Porter’s
17. Strategy mapping
18. Actinic keratosis treatment market - Unmet needs analysis
19. Consumer behavior analysis
20. Actinic keratosis treatment market: Therapy outlook and key takeaways
21. Actinic keratosis treatment market: Therapy movement analysis & market share 2021 & 2030
22. Surgery market estimates and forecast, 2018 - 2030 (USD Million)
23. Topical market estimates and forecast, 2018 - 2030 (USD Million)
24. Photodynamic therapy market estimates and forecast, 2018 - 2030 (USD Million)
25. Actinic keratosis treatment market: Drug Class outlook and key takeaways
26. Actinic keratosis treatment market: Drug Class movement analysis & market share 2021 & 2030
27. Nucleoside metabolic Inhibitor market estimates and forecast, 2018 - 2030 (USD Million)
28. NSAIDs market estimates and forecast, 2018 - 2030 (USD Million)
29. Immune response modifiers market estimates and forecast, 2018 - 2030 (USD Million)
30. Photoenhancers market estimates and forecast, 2018 - 2030 (USD Million)
31. Others market estimates and forecast, 2018 - 2030 (USD Million)
32. Actinic keratosis treatment market: End-use outlook and key takeaways
33. Actinic keratosis treatment market: End-use movement analysis & market share 2021 & 2030
34. Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
35. Private clinics market estimates and forecast, 2018 - 2030 (USD Million)
36. Homecare market estimates and forecast, 2018 - 2030 (USD Million)
37. Others market estimates and forecast, 2018 - 2030 (USD Million)
38. Actinic keratosis treatment market: Regional outlook and key takeaways
39. Regional outlook, 2021 & 2030
40. North America
41. North America market estimates and forecast, 2018 - 2030 (USD Million)
42. U.S.
43. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
44. Canada
45. Canada market estimates and forecast, 2018 - 2030 (USD Million)
46. Europe
47. Europe market estimates and forecast, 2018 - 2030 (USD Million)
48. U.K.
49. U.K. market estimates and forecast, 2018 - 2030 (USD Million)
50. Germany
51. Germany market estimates and forecast, 2018 - 2030 (USD Million)
52. France
53. France market estimates and forecast, 2018 - 2030 (USD Million)
54. Italy
55. Italy market estimates and forecast, 2018 - 2030 (USD Million)
56. Spain
57. Spain market estimates and forecast, 2018 - 2030 (USD Million)
58. Asia Pacific
59. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
60. Japan
61. Japan market estimates and forecast, 2018 - 2030 (USD Million)
62. China
63. China market estimates and forecast, 2018 - 2030 (USD Million)
64. India
65. India market estimates and forecast, 2018 - 2030 (USD Million)
66. South Korea
67. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
68. Australia
69. Australia market estimates and forecast, 2018 - 2030 (USD Million)
70. Latin America
71. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
72. Brazil
73. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
74. Mexico
75. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
76. Argentina
77. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
78. Middle East & Africa
79. MEA market estimates and forecast, 2018 - 2030 (USD Million)
80. South Africa
81. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
82. Saudi Arabia
83. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
84. UAE
85. UAE market estimates and forecast, 2018 - 2030 (USD Million)
86. Ansoff matrix
87. Market differentiators
88. Key company market share analysis, 2021
89. Company market position analysis
90. Company market position analysis
91. Competitive dashboard analysis
92. Regional network map
1. Actinic keratosis treatment market segmentation
2. Market research process
3. Data triangulation techniques
4. Primary research pattern
5. Market research approaches
6. Value-chain-based sizing & forecasting
7. QFD modeling for market share assessment
8. Market formulation & validation
9. Actinic keratosis treatment market snapshot
10. Parent market outlook
11. Related/ancillary market outlook, revenue, 2021, USD Billion
12. Penetration and growth prospect mapping
13. Actinic keratosis treatment market driver impact
14. Actinic Keratosis Treatment market restraint impact
15. SWOT analysis, by factor (Political & legal, economic, and technological)
16. Industry Analysis - Porter’s
17. Strategy mapping
18. Actinic keratosis treatment market - Unmet needs analysis
19. Consumer behavior analysis
20. Actinic keratosis treatment market: Therapy outlook and key takeaways
21. Actinic keratosis treatment market: Therapy movement analysis & market share 2021 & 2030
22. Surgery market estimates and forecast, 2018 - 2030 (USD Million)
23. Topical market estimates and forecast, 2018 - 2030 (USD Million)
24. Photodynamic therapy market estimates and forecast, 2018 - 2030 (USD Million)
25. Actinic keratosis treatment market: Drug Class outlook and key takeaways
26. Actinic keratosis treatment market: Drug Class movement analysis & market share 2021 & 2030
27. Nucleoside metabolic Inhibitor market estimates and forecast, 2018 - 2030 (USD Million)
28. NSAIDs market estimates and forecast, 2018 - 2030 (USD Million)
29. Immune response modifiers market estimates and forecast, 2018 - 2030 (USD Million)
30. Photoenhancers market estimates and forecast, 2018 - 2030 (USD Million)
31. Others market estimates and forecast, 2018 - 2030 (USD Million)
32. Actinic keratosis treatment market: End-use outlook and key takeaways
33. Actinic keratosis treatment market: End-use movement analysis & market share 2021 & 2030
34. Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
35. Private clinics market estimates and forecast, 2018 - 2030 (USD Million)
36. Homecare market estimates and forecast, 2018 - 2030 (USD Million)
37. Others market estimates and forecast, 2018 - 2030 (USD Million)
38. Actinic keratosis treatment market: Regional outlook and key takeaways
39. Regional outlook, 2021 & 2030
40. North America
41. North America market estimates and forecast, 2018 - 2030 (USD Million)
42. U.S.
43. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
44. Canada
45. Canada market estimates and forecast, 2018 - 2030 (USD Million)
46. Europe
47. Europe market estimates and forecast, 2018 - 2030 (USD Million)
48. U.K.
49. U.K. market estimates and forecast, 2018 - 2030 (USD Million)
50. Germany
51. Germany market estimates and forecast, 2018 - 2030 (USD Million)
52. France
53. France market estimates and forecast, 2018 - 2030 (USD Million)
54. Italy
55. Italy market estimates and forecast, 2018 - 2030 (USD Million)
56. Spain
57. Spain market estimates and forecast, 2018 - 2030 (USD Million)
58. Asia Pacific
59. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
60. Japan
61. Japan market estimates and forecast, 2018 - 2030 (USD Million)
62. China
63. China market estimates and forecast, 2018 - 2030 (USD Million)
64. India
65. India market estimates and forecast, 2018 - 2030 (USD Million)
66. South Korea
67. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
68. Australia
69. Australia market estimates and forecast, 2018 - 2030 (USD Million)
70. Latin America
71. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
72. Brazil
73. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
74. Mexico
75. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
76. Argentina
77. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
78. Middle East & Africa
79. MEA market estimates and forecast, 2018 - 2030 (USD Million)
80. South Africa
81. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
82. Saudi Arabia
83. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
84. UAE
85. UAE market estimates and forecast, 2018 - 2030 (USD Million)
86. Ansoff matrix
87. Market differentiators
88. Key company market share analysis, 2021
89. Company market position analysis
90. Company market position analysis
91. Competitive dashboard analysis
92. Regional network map
